WALTHAM, Massachusetts, Nov. 5 -- NEJM Evidence, a peer-reviewed journal from New England Journal of Medicine Group that says it presents clinical trial design and decision-making, published research articles on the following topics in its October 2024 edition (Vol. 3, No. 10):

Original Articles

* European Society of Cardiology: Ertugliflozin to Reduce Arrhythmic Burden in Patients with ICDs/CRT-Ds

* Tecovirimat Use under Expanded Access to Treat Mpox in th . . .

Click here for more information about our products